LipoScience Inc

Entity type image
Type: Company
Name: LipoScience Inc
First reported 4 hours ago - Updated 4 hours ago - 3 reports

LIPOSCIENCE INC. : LipoScience's Vantera® Clinical Analyzer To Provide Hospitals And Physicians With Lipoprotein Analysis For Cardiovascular Disease Management

(4-traders.com)RALEIGH, N.C., May 22, 2013/PRNewswire/ -- LipoScience, Inc.,  (NASDAQ:  LPDX) a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care, today announced ... [Published 4 Traders - 4 hours ago]
First reported May 17 2013 - Updated May 17 2013 - 1 reports

LipoScience, Inc. (LPDX) - Strategic SWOT Analysis Review - new company profile report

LipoSceince, Inc. (LipoScience) is a diagnostic testing company. The company develops proprietary tests based on Nuclear Magnetic Resonance (NMR), a technology that produces a digital analysis of molecules present in a blood sample. The company's flagship ... [Published TransWorldNews - May 17 2013]
First reported May 16 2013 - Updated May 16 2013 - 1 reports
Select Medical Holdings Corp
Select Medical Holdings Corp

Distressed Investor Wilbur Ross Buys 2 Stocks

Billionaire Wilbur Ross primarily invests in failed companies and leveraged buyouts. His business deals typically involve industries such as coal, steel, telecommunications, foreign investment and textiles.Ross' investment company, Invesco Private Capital ... [Published Nasdaq - May 16 2013]
First reported May 14 2013 - Updated May 14 2013 - 3 reports
UBS AG
UBS AG

LipoScience, Inc. to Present at UBS Global Healthcare Services Conference

(GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that Richard Brajer, President and Chief Executive Officer, and Lucy Martindale, Executive Vice President and Chief Financial Officer, will present at the UBS Global Healthcare Services ... [Published BioSpace - May 14 2013]
First reported May 13 2013 - Updated May 13 2013 - 1 reports
DURECT Corp
DURECT Corp

NASDAQ Decliners Watch List: LipoScience, Inc. (NASDAQ:LPDX) and DURECT Corporation (NASDAQ:DRRX) Added to Growing Stock Report's NASDAQ Decliners Watch List.

New York, NY -- (SBWIRE) -- 05/13/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding LipoScience, Inc. (NASDAQ:LPDX) and DURECT Corporation (NASDAQ:DRRX).LipoScience, Inc. (NASDAQ:LPDX) an in vitro diagnostic company that ... [Published SBWire - May 13 2013]
First reported May 10 2013 - Updated May 10 2013 - 1 reports

LipoScience Inc Lowers FY 2013 Revenue Guidance

LipoScience Inc announced that based on a comprehensive review, the four primary factors contributing to the first quarter 2013 revenue shortfall were, the Company were unable to get the needed number of new sales representatives up and running, Direct ... [Published Reuters UK - May 10 2013]
First reported May 09 2013 - Updated May 09 2013 - 1 reports

LipoScience disappoints in debut quarterly report

Fresh from a Jan. 25 initial public offering, LipoScience Inc. (Nasdaq: LPDX) released a disappointing first-quarter financial report on Thursday afternoon, with CEO Richard Brajer saying he was “dissatisfied” with revenue performance and unit growth ... [Published Triangle Business Journal - May 09 2013]
First reported May 09 2013 - Updated May 09 2013 - 2 reports

LipoScience Reports First Quarter 2013 Financial Results GlobeNewswire

First Quarter 2013 NMR LipoProfile(R) Test Volumes Up 8.7% from 2012 PeriodAnnounces Mayo Clinic Preparation for "Go Live" of Clinical Reporting on Vantera(R) System and Inclusion in American Association of Clinical Endocrinologists Diabetes Management ... [Published Yahoo! Finance - May 09 2013]
First reported May 09 2013 - Updated May 09 2013 - 1 reports

LipoScience Reports First Quarter 2013 Financial Results

CONTACT: Investor Relations:ICR, Inc. Bob YedidManaging Director (919) 256-1183bob.yedid@icrinc.comLipoScience, Inc.Tori Hall tori.hall@liposcience.com(919) 256-1 ... [Published Reuters - May 09 2013]
First reported May 07 2013 - Updated May 07 2013 - 1 reports

LipoScience initiates clinical development of cardiovascular diagnostic test

LipoScience, Inc., a diagnostic company, has announced the initiation of the clinical development phase of a diagnostic test for cardiovascular disease based upon research demonstrating that a gut flora metabolite, trimethylamine-N-oxide, or TMAO, is ... [Published Individual.com - May 07 2013]
First reported May 02 2013 - Updated May 02 2013 - 1 reports

LIPOSCIENCE INC.: LipoScience to Release First Quarter Fiscal Year 2013 Financial Results

(GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that it will release its first quarter of fiscal year 2013 financial results after the market close on Thursday, May 9, 2013. An investor conference call will follow on the same day at ... [Published 4 Traders - May 02 2013]
First reported May 02 2013 - Updated May 02 2013 - 2 reports

LipoScience to Release First Quarter Fiscal Year 2013 Financial Results

(GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that it will release its first quarter of fiscal year 2013 financial results after the market close on Thursday, May 9, 2013. An investor conference call will follow on the same day at ... [Published BizWire Express - May 02 2013]

Quotes

...Amy Saenger, Ph D is the Director of Cardiovascular Laboratory Medicine at Mayo Clinic and stated "We are excited to offer LDL-P and other NMR lipoprotein profiles, enhancing our extensive and expanding cardiovascular disease test menu." Mayo Medical Laboratories and the Cardiovascular Laboratory will continue their close scientific collaboration with LipoScience to develop new NMR-based...
LipoScience's Vantera Clinical Analyzer To Provide Hospitals And Physicians With Lipoprotein Anal ... [Published FinanzNachrichten.de - 4 hours ago]
See Wilbur Ross " portfolio here . Also check out the Undervalued Stocks, Top Growth Companies and High Yield stocks of Wilbur Ross.About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members . The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group Inc."
Distressed Investor Wilbur Ross Buys 2 Stocks [Published Nasdaq - May 16 2013]
...3% LOWER; announced that Pfizer has provided an update on Remoxy as part of their Form 10-Q filing. Pfizer's disclosure is as follows: "In 2005, King Pharmaceuticals Inc. (King) entered into an agreement with Pain Therapeutics Inc. (PT) to develop and commercialize Remoxy. In August 2008, the FDA accepted the NDA for Remoxy that had been submitted by King and PT. Pfizer"
Unusual 11 Mid-Day Movers 05/10: (UNIS) (DRAM) (MCP) Higher; (PTIE) (DRRX) (AFFY) Lower [Published Street Insider - May 10 2013]
...our unit growth and revenue performance, and our responses are already underway," commented Richard Brajer, President and Chief Executive Officer. "Based on a comprehensive review, the four primary factors contributing to the first quarter 2013 revenue shortfall were 1) we were unable to get the needed number of new sales representatives up and running, 2) our direct business is converting to our lab partners at a faster rate than prior years, 3) managed care headwinds, and 4) Vantera system placement delays."
LipoScience Reports First Quarter 2013 Financial Results GlobeNewswire [Published Yahoo! Finance - May 09 2013]

More Content

All (47) | News (26) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (20)
sort by: Date | Relevance
LIPOSCIENCE INC. : LipoScience's Vantera® Clini... [Published 4 Traders - 4 hours ago]
LipoScience's Vantera Clinical Analyzer To Prov... [Published FinanzNachrichten.de - 4 hours ago]
LipoScience's Vantera® Clinical Analyzer To Pr... [Published Individual.com - 4 hours ago]
LipoScience's Vantera® Clinical Analyzer To Pro... [Published PR Newswire: Health - 4 hours ago]
LipoScience, Inc. (LPDX) - Strategic SWOT Analy... [Published TransWorldNews - May 17 2013]
Distressed Investor Wilbur Ross Buys 2 Stocks [Published Nasdaq - May 16 2013]
10-Q - LIPOSCIENCE INC (0001168197) (Filer) [Published SEC - May 14 2013]
LipoScience, Inc. to Present at UBS Global Heal... [Published BioSpace - May 14 2013]
LipoScience to Present at UBS Global Healthcare... [Published Reuters - May 14 2013]
LipoScience to Present at UBS Global Healthcare... [Published GlobeNewswire: Acquisitions News - May 14 2013]
LipoScience to Present at UBS Global Healthcare... [Published Yahoo! Finance - May 14 2013]
NASDAQ Decliners Watch List: LipoScience, Inc. ... [Published SBWire - May 13 2013]
Unusual 11 Mid-Day Movers 05/10: (UNIS) (DRAM) ... [Published Street Insider - May 10 2013]
Stocks Hitting 52-Week Lows [Published TD Ameritrade - May 10 2013]
LipoScience Inc Lowers FY 2013 Revenue Guidance [Published Reuters UK - May 10 2013]
LipoScience disappoints in debut quarterly report [Published Triangle Business Journal - May 09 2013]
LipoScience Reports First Quarter 2013 Financia... [Published Yahoo! Finance - May 09 2013]
LipoScience Reports First Quarter 2013 Financia... [Published Reuters - May 09 2013]
LipoScience Reports First Quarter 2013 Financia... [Published StockHouse USA - May 09 2013]
LipoScience initiates clinical development of c... [Published Individual.com - May 07 2013]
LIPOSCIENCE INC.: LipoScience to Release First ... [Published 4 Traders - May 02 2013]
LipoScience to Release First Quarter Fiscal Yea... [Published BizWire Express - May 02 2013]
LipoScience to Release First Quarter Fiscal Yea... [Published Reuters - May 02 2013]
LipoScience to Release First Quarter Fiscal Yea... [Published GlobeNewswire: Acquisitions News - May 02 2013]
LipoScience Begins Clinical Development of NMR-... [Published FierceBiotech - Apr 29 2013]
LipoScience Begins Clinical Development of NMR-... [Published Business Wire Science: Science News - Apr 25 2013]
LipoScience Begins Clinical Development of NMR-... [Published Business Wire Health News - Apr 25 2013]
Atossa Genetics, Inc. (NASDAQ:ATOS), Velti Plc ... [Published SBWire - Apr 21 2013]
LipoScience Added to the Russell 3000(R) & 2000... [Published GlobeNewswire: Acquisitions News - Apr 01 2013]
8-K - LIPOSCIENCE INC (0001168197) (Filer) [Published SEC Filings - Mar 27 2013]
1 2
In Focus
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
LipoScience IPO Prices Weak but Debuts Strong [Published 24/7 Wall St. - Jan 25 2013]
LipoScience Inc. (NASDAQ: LPDX) is now open as a public company, now that its initial public offering has priced and begun trading. This was an under-the-radar IPO, and some investors may not know... ...
1

Press Releases

sort by: Date | Relevance
LipoScience's Vantera® Clinical Analyzer To Pro... [Published PR Newswire: Health - 4 hours ago]
LipoScience to Present at UBS Global Healthcare... [Published GlobeNewswire: Acquisitions News - May 14 2013]
LipoScience to Release First Quarter Fiscal Yea... [Published GlobeNewswire: Acquisitions News - May 02 2013]
LipoScience Begins Clinical Development of NMR-... [Published Business Wire Science: Science News - Apr 25 2013]
LipoScience Begins Clinical Development of NMR-... [Published Business Wire Health News - Apr 25 2013]
1 2 3 4
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.